Medik8
- Company typePrivate
- Founded2009
- HeadquartersElstree, United Kingdom
- Headcount101–250
- GTM typeB2C
- OfferingHardware or Manufacturing
Medik8 firmographics
Firmographics- Name
- Medik8
- Legal name
- Medik8
- Website
- https://www.medik8.com/
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Medik8 industry classification
Industry- Product category
- Clinical Skincare
- NAICS
- Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Health and Personal Care Retailers (4561)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Professional Skincare & Facial Treatments (CRABALAF), Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)
Keywords
Where Medik8 is headquartered
LocationHeadquarters
- HQ city
- Elstree
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Medik8 business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Revenue model
- Direct-to-Consumer (DTC) E-commerce: Medik8 generates revenue through its owned e-commerce platform (medik8.com), selling skincare products directly to consumers with loyalty rewards (Me&Medik8) and promotional discounts (15% first order, seasonal sales).
- Retail Partnership (Sephora): Revenue generated through Sephora retail partnership in North America, selling Crystal Retinal and other products through Sephora.com, Sephora.ca, and 250+ U.S. and 147 Canadian retail stores.
- Professional/Clinic Channel: Medik8 distributes through a network of certified clinics and professional stockists, with a clinic locator on its website and professional treatment offerings, supporting sales through practitioner recommendations.
- Wholesale/Distribution (Space NK and others): Medik8 products are available through UK and international specialty beauty retailers including Space NK, with pop-up activations and retail distribution partnerships.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Crystal Retinal 24 — £109 per 30ml |
| Unit Pricing | Pay-as-you-go | Exo-PDRN Prismatic+ — £79 |
| Other | Monthly | Me&Medik8 Loyalty Program — Free to join |
| Other | Pay-as-you-go | Promotional pricing — up to 20% off |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
Medik8 product offering
Product offeringCore offering
Medik8 manufactures and sells a range of clinical skincare products centered on vitamin A (retinaldehyde) technology, anchored by its flagship Crystal Retinal line (available in strengths 1–24) and complemented by peptide serums, vitamin C serums, hyaluronic acid hydrators, cleansers, moisturizers, eye care, and SPF sunscreens. Products are formulated and clinically validated in-house, organized around the proprietary CSA philosophy (Cleansing, Sunscreen, Active), and sold direct-to-consumer, through retail partners such as Sephora and Space NK, and via a certified clinic/professional channel.
Product overview
Medik8 is a British clinical skincare brand offering a science-led product portfolio centered on its core vitamin A (retinaldehyde) technology. The flagship Crystal Retinal franchise serves as the anchor product line, supported by complementary serums (Liquid Peptides, C-Tetra Advanced, Hydr8 B5 Intense, Exo-PDRN Prismatic+), moisturizers (Advanced Night Restore, Total Moisture), cleansers, and SPF sunscreens. The brand follows a CSA philosophy (vitamin C + Sunscreen + vitamin A) for daily skincare regimens. Medik8 also offers a professional treatments division for clinic-based services and a loyalty program (Me&Medik8). The products range from entry-level to advanced clinical-strength formulations, with Crystal Retinal available in strengths from 1 to 24 and the brand claiming the title of world's No.1 Retinal Serum per independent Kline & Company research.
Differentiator
Problem solved
Functional benefit
Products and services
- Crystal Retinal Flagship vitamin A (retinaldehyde) night serum and the world's No. 1 Retinal Serum per Kline & Company market research. Available in multiple strengths (1–24) with patented crystal encapsulation technology for stable retinal delivery; clinically shown to reduce fine lines and wrinkles within 7 days.
- Crystal Retinal Ceramide Eye Eye-specific retinal formulation with ceramides for targeted anti-aging around the delicate eye area.
- Exo-PDRN Prismatic+ Youthful Vitality Serum Advanced serum featuring Tri-Exosome Complex with Prismatic PDRN technology. Contains up to 151 billion exosomes per bottle. Designed for skin recovery and optimal resilience with visible improvements in skin health, vitality, and luminosity within 7 days per a 4-week clinical study.
- Liquid Peptides Advanced MP Multi-peptide serum designed to improve skin firmness and reduce the appearance of fine lines and wrinkles; Advanced MP version is a best-selling peptide formula.
- C-Tetra Advanced Vitamin C serum featuring stabilized vitamin C in a lightweight gel-serum texture for antioxidant protection and brightening.
- Hydr8 B5 Intense Intense hydration serum featuring hyaluronic acid to deeply moisturize and plump the skin.
- Total Moisture Daily Cleansing Gel Daily facial cleanser that removes impurities while maintaining skin barrier integrity, part of Medik8's CSA regimen philosophy.
- Total Moisture Daily Facial Cream Moisturizer providing daily hydration and skin barrier support as part of Medik8's CSA philosophy regimen.
- Advanced Night Restore Rejuvenating multi-ceramide night cream designed to restore and replenish skin overnight while supporting skin barrier health.
- Sunscreen / SPF Products Range of sunscreen products spanning SPF protection categories; Medik8 positions as a sunscreen specialist with daily protection as a core pillar of the CSA philosophy.
- Medik8 Professional Treatments Professional-grade skincare treatments available through certified clinics, offering in-office aesthetic procedures using Medik8 formulations.
Quantifiable outcome
- Crystal Retinal reduces the appearance of fine lines and wrinkles within 7 days (clinical study on 30 participants over 24 weeks)
- +4 more outcomes
Companies that use Medik8
Customer profileSegments4 records
Ideal customer profiles2 records
Medik8 technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Medik8 partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and core.
- SephoraflagshipMedik8 partnered with Sephora for a major North American expansion, launching on Sephora.com and Sephora.ca on August 11, 2025, with rollout to 250 U.S. stores and 147 Canadian stores by August 21, 2025. The partnership aims to establish Crystal Retinal as a leading U.S. skincare franchise with a target of £100 million in North American retail sales by 2029. L'Oréal Groupe's acquisition of Medik8 provided the resources to scale this distribution partnership.
- Space NKcoreMedik8 partnered with Space NK for a two-day science-led skincare experience pop-up in Covent Garden, London, to launch its Exo-PDRN Prismatic+ product. The activation featured personalized skin analysis sessions, consultations, and product samples. This was Medik8's first discovery-led consumer activation with Space NK, marking a strategic retail partnership for brand discovery and consumer education in the UK prestige beauty market.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Medik8 competitors and assessment
Company assessmentDirect peers
- SkinCeuticals: SkinCeuticals is the leading medical-grade clinical skincare brand owned by L'Oréal, focused on vitamin C, antioxidants, and corrective anti-aging treatments sold through dermatologists, med-spas, and prestige retail — directly comparable to Medik8's clinical positioning and now its sister brand under L'Oréal.
- Obagi Cosmeceuticals: Obagi is a physician-dispensed clinical skincare brand built around prescription-grade actives (vitamin A, hydroquinone, vitamin C) for anti-aging and hyperpigmentation, mirroring Medik8's clinical/dermatologist channel and retinaldehyde-led proposition.
- PCA Skin: PCA Skin is a professional skincare brand sold through licensed estheticians and clinics, offering treatment-grade peels and actives — directly comparable to Medik8's Medik8 Professional channel and CSA clinical regimen philosophy.
- iS Clinical: iS Clinical is a science-driven, physician-dispensed skincare brand with active-based serums and post-procedure protocols, paralleling Medik8's clinical claims, ingredient-led marketing, and professional/clinical channel distribution.
- Alastin Skincare: Alastin (owned by Galderma) is a physician-dispensed clinical skincare brand built on patented TriHex Technology for procedure-adjacent skincare and anti-aging — a direct comparator in the clinical skincare, professional-channel category where Medik8 competes.
- Augustinus Bader: Augustinus Bader is a premium clinical/biotech skincare brand positioned on patented TFC8 cell-communication technology at prestige price points, directly comparable to Medik8's premium clinical positioning and emerging exosome/PDRN biotech narrative.
- Dermalogica: Dermalogica is a professional-grade skincare brand with a strong skin therapist/professional channel and structured regimen philosophy, closely paralleling Medik8's CSA philosophy, professional clinic channel, and regimen-builder approach.
- Elemis: Elemis is a British premium skincare brand with science-led anti-aging formulations sold through DTC, department stores, spas, and cruise/hotel channels — a closely comparable UK-origin clinical/premium skincare peer competing in overlapping channels and price tiers.
- Drunk Elephant: Drunk Elephant is a clinically positioned, active-ingredient skincare brand (owned by Shiseido) sold through Sephora and DTC — directly comparable to Medik8 on the Sephora US channel and on active-ingredient/biotech positioning.
- Dr. Dennis Gross Skincare: Dr. Dennis Gross is a dermatologist-founded clinical skincare brand with patented acid peels and active serums at prestige price points — a direct comparator in the dermatologist-led, clinical skincare peer set.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Medik8 social profiles
Digital presenceMedik8 compliance and trust
Trust signalCompliance1 record
Medik8 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medik8 leadership team
Management profileNumber of profiles
Profiles1 record
Medik8 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medik8 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medik8
What does Medik8 do?
Medik8 manufactures and sells a range of clinical skincare products centered on vitamin A (retinaldehyde) technology, anchored by its flagship Crystal Retinal line (available in strengths 1–24) and complemented by peptide serums, vitamin C serums, hyaluronic acid hydrators, cleansers, moisturizers, eye care, and SPF sunscreens. Products are formulated and clinically validated in-house, organized around the proprietary CSA philosophy (Cleansing, Sunscreen, Active), and sold direct-to-consumer, through retail partners such as Sephora and Space NK, and via a certified clinic/professional channel.
Is Medik8 a public or private company?
Medik8 is a private company. It is classified as corporate owned and is currently operating.
When was Medik8 founded?
Medik8 was founded in 2009. It employs 101 to 250 people.
Where is Medik8 based?
Medik8 is headquartered in Elstree, United Kingdom, in the Europe region.
How does Medik8 make money?
Four revenue lines are on record. Direct-to-Consumer (DTC) E-commerce is the primary driver. The others are retail Partnership (Sephora), professional/Clinic Channel and wholesale/Distribution (Space NK and others).
Who are Medik8's main competitors?
Direct peers on record are SkinCeuticals, Obagi Cosmeceuticals, PCA Skin, iS Clinical, Alastin Skincare, Augustinus Bader, Dermalogica, Elemis, Drunk Elephant and Dr. Dennis Gross Skincare.
Does Medik8 have an API?
No public API is recorded for Medik8.
What industry is Medik8 in?
Medik8's product category is Clinical Skincare. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRABALAF, Professional Skincare & Facial Treatments. Its NAICS code is 456120 and its SIC code is 2844.